Zimmer Biomet Holdings (ZBH) Total Debt Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.96% |
| Dec 31, 2025 | -1.54% |
| Sep 30, 2025 | -0.43% |
| Jun 30, 2025 | -1.60% |
| Mar 31, 2025 | -5.80% |
| Dec 31, 2024 | -5.47% |
| Sep 30, 2024 | -5.02% |
| Jun 30, 2024 | -7.72% |
| Mar 31, 2024 | -8.03% |
| Dec 31, 2023 | -8.39% |
| Sep 30, 2023 | -9.83% |
| Jun 30, 2023 | 122.84% |
| Mar 31, 2023 | 28.87% |
| Dec 31, 2022 | -10.90% |
| Sep 30, 2022 | 35.98% |
| Jun 30, 2022 | 35.20% |
| Mar 31, 2022 | -11.36% |
| Dec 31, 2021 | 64.90% |
| Sep 30, 2021 | 66.86% |
| Jun 30, 2021 | 73.15% |
| Mar 31, 2021 | 342.89% |
| Sep 30, 2020 | 105.72% |
| Jun 30, 2020 | 93.84% |
| Mar 31, 2020 | 1.32% |
| Dec 31, 2019 | 163.93% |
| Sep 30, 2019 | 101.06% |
| Jun 30, 2019 | 38.88% |
| Mar 31, 2019 | 39.29% |
| Dec 31, 2018 | 409.64% |
| Sep 30, 2018 | 40.40% |
| Jun 30, 2018 | -42.74% |
| Mar 31, 2018 | -0.88% |
| Dec 31, 2017 | 40.99% |
| Sep 30, 2017 | -6.66% |
| Jun 30, 2017 | -5.07% |
| Mar 31, 2017 | 46.31% |
| Dec 31, 2016 | -19.54% |
| Sep 30, 2016 | -17.77% |
| Jun 30, 2016 | -15.15% |
| Mar 31, 2016 | -66.80% |
| Sep 30, 2015 | -27.70% |
| Jun 30, 2015 | -23.31% |
| Mar 31, 2015 | 51.72% |
| Dec 31, 2014 | -43.63% |
| Sep 30, 2014 | -15.80% |
| Jun 30, 2014 | 20.89% |